American Depositary Receipts

Sanofi shares are listed on the Euronext Paris and are also available on the Nasdaq Global Select Market (Nasdaq) in the form of American Depositary Shares (ADS) under the symbol SNY. Between July 1, 2002 and December 31, 2018, Sanofi ADSs were listed on the New York Stock Excange (NYSE).
JPMorgan Chase Bank acts as a depositary of our ADSs and issues American Depositary Receipts (ADRs) for these shares entitling the shareholder to all dividends and capital gains.

A dedicated team is available in the U.S. to answer the questions of U.S. investors and individual shareholders.

ADRs Program

ADR Program

Sponsored level II ADR program

Sanofi stock is traded under a sponsored level II ADR program on the Nasdaq, thereby offering a higher visibility in the U.S. market, more active trading and greater liquidity. Level II ADR programs must comply with the full registration and reporting requirements of the U.S. Securities and Exchange Commission (SEC) for foreign private issues. This entails, among other things, the filing of a Form 20-F registration statement to register the listing of ADRs, including financial statements and a reconciliation of those statements to U.S. GAAP, and the filing of an annual report on Form 20-F for each year following the initial registration.

How to purchase ADRs

To purchase Sanofi ADRs, shareholders may contact a licensed stockbroker or may buy directly from our ADR depository bank, JPMorgan Chase, through a Direct Purchase Plan. The Plan provides first-time purchasers and existing shareholders of Sanofi ADSs with a convenient and economical way to invest in Sanofi. Participants can enjoy the same benefits as an investor who holds physical certificates; they remain the registered owner of the shares and have full control over their investment decisions.

ADRs Dividends

ADR Dividends

Dividend reinvestment plan

Dividends are paid by check, or they may be directly deposited into a bank account of your choice. Please let your brokerage or JPMorgan Chase Bank know how you would like to receive your dividend.
As a Direct Purchase Plan participant, you may elect to reinvest all or a portion of your cash dividends in additional shares. To do so, you will have to check the applicable box on the enrollment form.

Income Tax Information

ADR dividends are paid in U.S. dollars and are generally taxable, just like dividends on U.S. shares. In addition, the Republic of France, Sanofi’s home country, may withhold taxes. Depending on individual circumstances, foreign taxes withheld might be applied as a credit against U.S. taxes, or tax reclaim opportunities may be offered. For specific information, consult your tax adviser.

You may also call Goal Global Recoveries on 212-248-9130
To obtain further tax information, please read our current annual report on Form 20-F filed with the Securities and Exchange Commission.

Approximate information for 2019 dividends

The Annual General Meeting 2020 approved a dividend of €3.15 per ordinary share for 2019 results.
Record date for ADRs: May 1, 2020 
Payment/value date for ADRs: May 26, 2020

Dividend per ordinary share €3.15
Ratio ADR:ordinary share 1:2
Dividend per ADR €1.575
Foreign exchange date 03/04/2020
Final foreign exchange rate*
Inclusive of a fee of 0.002300
1.1133
Withholding tax rate 0% 12.8% 15% 28%
Rate per DR 1.7534475 1.7534475 1.7534475 1.7534475
Withholding amount $0.0 $0.2244412 $0.2630171 $0.4909653
Dividend fee $0.05 $0.05 $0.05 $0.05
DSC 0.008000 0.008000 0.008000 0.000000
Final dividend rate per DR $1.6954475 $1.4710063 $1.4324304 $1.2124822

Final information for 2018 dividends

The Annual General Meeting 2019 approved a dividend of €3.07 per ordinary share for 2018 results.
Record date for ADRs: May 8, 2019 
Payment/value date for ADRs: May 31, 2019

Dividend per ordinary share €3.07
Ratio ADR:ordinary share 1:2
Dividend per ADR €1.535
Foreign exchange date 02/22/2019
Final foreign exchange rate*
Inclusive of a fee of 0.002300
1.1332
Withholding tax rate 0% 12.8% 15% 30%
Rate per DR 1.739462 1.739462 1.739462 1.739462
Withholding amount $0.0 $0.222651 $0.260919 $0.521838
Dividend fee $0.05 $0.05 $0.05 $0.05
DSC 0.008000 0.008000 0.008000 0.000000
Final dividend rate per DR $1.681462 $1.458811 $1.420543 $1.167624

*Funds provided to J. P. Morgan in a foreign currency may have been converted to U.S. dollars through a foreign exchange transaction with J. P. Morgan or an affiliate. The foreign exchange rate applied to the foreign currency is determined by J.P. Morgan in its sole discretion and is either (1) the WMR Rate or (2) the JP Morgan Rate plus, in either case, up to 20 basis points.
J.P. Morgan collects fees ("Fees") from holders of depositary receipts. These Fees are described in the deposit agreement and may include, without limitation, Fees for (i) the issuance and cancellation of depositary receipts, (ii) services performed in administering the depositary receipts and (iii) distributions of cash. In most cases, J.P. Morgan reimburses the issuer for certain expenses related to the depositary receipts program and incurred by the issuer in connection with such program or shares revenue with the issuer received by J.P. Morgan from such Fees or revenues generated in connection with the Program.

History of Sanofi annual dividends per ADR

Amount Record date Payment/Value date
2018 $1.74 May 8, 2019 May 31, 2019
2017 $1.86 May 10, 2018 June 4, 2018
2016 $1.64 May 15, 2017 June 7, 2017
2015 $1.66 May 9, 2016 June 1, 2016
2014 $1.61 May 8, 2015 June 2, 2015
2013 $1.91 May 9, 2014 June 5, 2014
2012 $1.86 May 8, 2013 June 5, 2013
2011 $1.75 May 9, 2012 May 30, 2012
2010 $1.82 May 13, 2011 June 24, 2011
2009 $1.47 May 19, 2010 June 14, 2010
2008 $1.44 April 22, 2009 May 29, 2009
2007 $1.51 May 20, 2008 June 13, 2008

Contact JPMorgan Chase Bank

Regular correspondence:
JPMorgan Chase Bank, NA
P.O. BOX 64504
St. Paul, MN 55164-0504

Toll-free number in the U.S.: (1) 877 272 9475
For international callers: (1) 651 453 2128
Email: jpmorgan.adr@eq-us.com

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK